NovoCure Ltd·4

Nov 4, 4:34 PM ET

Puri Michal Nath 4

4 · NovoCure Ltd · Filed Nov 4, 2024

Insider Transaction Report

Form 4
Period: 2024-10-31
Puri Michal Nath
Chief Human Resources Officer
Transactions
  • Sale

    Ordinary Shares

    2024-10-31$15.79/sh810$12,792110,093 total
Footnotes (2)
  • [F1]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
  • [F2]This transaction was executed in multiple trades at prices ranging from $15.48 USD to $16.01 USD; the price reported above reflects the weighted average sale price.

Documents

2 files
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT

  • EX-24

    EX-24 POA - MICHAL NATH PURI